Shares of Chewy (CHWY) are higher in choppy premarket trading as Wall Street digests the pet retailer’s mixed second-quarter ...

European court backs EU block of Booking’s $1.9B ETraveli deal, citing competition risks and dominance in online travel.

Jefferies starts Liberty Media Formula One (FWONK) with a Buy and $115 PT, citing Apple TV and MotoGP upside, margin gains ...

Fanatics launches unified Sports & Casino app combining sportsbook, online casino & prediction markets with one wallet and ...

Inhibrx (INBX) updates: ozekibart & INBRX-106 show strong rare cancer and immuno-oncology data; FDA BLA due Apr 2027.

Solstice Advanced Materials is rated Hold, as the market already prices in much of the anticipated margin and FCF improvement ...

NVIDIA delivered Q2 FY27 revenue of $96.2B, surpassing guidance and driving shares up 8.7%. See why I rate NVDA stock a Buy ...

Tyra Biosciences (TYRA) stock slides as the company posts initial results from a Phase 2 trial for its lead candidate ...

Dyne Therapeutics lead asset z-rostudirsen faces regulatory and confirmatory risks, with FDA approval likely. Find out why ...

Snowflake delivered strong Q2 results, with accelerating top line growth and robust free cash flow driven by enterprise ...

SIFCO delivered 18% revenue growth in Q3, while nine-month revenue remains up 23.5% and broadly on track with my FY2026 ...

UFC/WWE media rights, scalable IP monetization, and 2026 revenue/EBITDA outlook support 26% upside—review key risks now.